top of page

Avenir Capital Proudly Supports one of their AFSL Authorised Representatives, SoHi Partners’ Ambitious Medtech Venture!

anyahaywood
Jun 3, 20242 min read

Avenir Capital's AFSL Authorised Representative, Andrew Speers, founding partner and chief operating officer of SoHi Partners featured in the AFR
Avenir Capital's AFSL Authorised Representative, Andrew Speers, founding partner and chief operating officer of SoHi Partners featured in the AFR May, 2024

We are thrilled to announce that Avenir Capital's AFSL authorised representative, SoHi Partners, has been featured in the Australian Financial Review for their innovative approach to venture capital in the medical technology sector.


SoHi Partners, a $50 million venture capital fund based in the Southern Highlands, is spearheaded by orthopaedic surgeons Nick Hartnell and Ashish Diwan. With 40 patents between them, they bring unparalleled expertise to the table, aiming to outperform traditional investment bankers and fund managers in commercialising medical research. Within just two months of launching their first fund, SoHi has secured $12 million in commitments, primarily from other surgeons and doctors.


Joining Dr. Hartnell and Dr. Diwan in the launch of SoHi are Andrew Speers and John Bullwinkel. These partners bring a wealth of experience from their backgrounds in banking, as well as executive roles at Westfield and Lendlease, further strengthening the fund’s leadership team.


SoHi Partners focuses on investing in medical start-ups with the potential to significantly improve patient outcomes and generate substantial returns. They are particularly interested in companies with a global market potential of $1.5 billion and the capability to deliver a 20-fold capital return. Dr. Hartnell and Dr. Diwan's own start-ups, Ginan Biomedics and Cartago Biotech, are among the promising ventures likely to benefit from SoHi’s support.


Avenir Capital is incredibly proud to support the endeavours of high-quality groups like SoHi Partners. We believe in their mission to drive medical innovation and are excited to play a role in their journey to transform healthcare and improve lives globally.


We look forward to sharing more updates on the groundbreaking work of SoHi Partners and other exciting ventures supported by Avenir Capital!



*photo courtesy of The AFR.



 

 

 

 


 
 
 

Comments

Avenir Capital Pty Ltd (ACN 150 790 355) holds a broad-ranging wholesale Australian Financial Services Licence

(AFSL 405469), issued in & blemish-free since 2011 and provides an AFSL Authorised Representative and compliance support services

Contact us today for an obligation free consult.

Head of Business Development: Anya Haywood +61 438 355 002

ahaywood@avenircapital.com.au

©2022 by Avenir Capital. 

We acknowledge the traditional custodians of the land where we work and live, and we pay our respects to Elders past, present and emerging. We celebrate the stories, culture and traditions of Aboriginal and Torres Strait Islander communities who work and live on this land, and commit to an ongoing journey of reconciliation and respect.

General: This website contains information about us at Avenir Capital Ltd (AFSL No. 405469) and the services and products we provide.
Avenir Capital does not warrant that the functions contained in the website will be uninterrupted or error-free, that defects will be corrected or that this site or the server that makes such contents available are free of viruses or other harmful components. The information contained on this website is provided by Avenir Capital Ltd in good faith. Avenir Capital Ltd does not warrant or make any representations regarding the use or the results of the use of the contents on this site in terms of their correctness, accuracy, reliability, or otherwise. The terms "AFSL for hire" or "AFSL rental services" are colloquial terms and sometimes used in the industry to describe the services provided by an AFSL Authorised Representative.

bottom of page